Obesity and prostate cancer: weighing the evidence
- PMID: 23219374
- PMCID: PMC3597763
- DOI: 10.1016/j.eururo.2012.11.013
Obesity and prostate cancer: weighing the evidence
Abstract
Context: Obesity and prostate cancer (PCa) affect substantial proportions of Western society. Mounting evidence, both epidemiologic and mechanistic, for an association between the two is of public health interest. An improved understanding of the role of this modifiable risk factor in PCa etiology is imperative to optimize screening, treatment, and prevention.
Objective: To consolidate and evaluate the evidence for an epidemiologic link between obesity and PCa, in addition to examining the proposed underlying molecular mechanisms.
Evidence acquisition: A PubMed search for relevant articles published between 1991 and July 2012 was performed by combining the following terms: obesity, BMI, body mass index and prostate cancer risk, prostate cancer incidence, prostate cancer mortality, radical prostatectomy, androgen-deprivation therapy, external-beam radiation, brachytherapy, prostate cancer and quality of life, prostate cancer and active surveillance, in addition to obesity, BMI, body mass index and prostate cancer and insulin, insulin-like growth factor, androgen, estradiol, leptin, adiponectin, and IL-6. Articles were selected based on content, date of publication, and relevancy, and their references were also searched for relevant articles.
Evidence synthesis: Increasing evidence suggests obesity is associated with elevated incidence of aggressive PCa, increased risk of biochemical failure following radical prostatectomy and external-beam radiotherapy, higher frequency of complications following androgen-deprivation therapy, and increased PCa-specific mortality, although perhaps a lower overall PCa incidence. These results may in part relate to difficulties in detecting and treating obese men. However, multiple molecular mechanisms could explain these associations as well. Weight loss slows PCa in animal models but has yet to be fully tested in human trials.
Conclusions: Obesity appears to be linked with aggressive PCa. We suggest clinical tips to better diagnose and treat obese men with PCa. Whether reversing obesity slows PCa growth is currently unknown, although it is an active area of research.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3597763/bin/nihms421493f1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3597763/bin/nihms421493f2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3597763/bin/nihms421493f3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3597763/bin/nihms421493f4.gif)
Similar articles
-
Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17. BJU Int. 2012. PMID: 22094083 Free PMC article.
-
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.Prescrire Int. 2012 Oct;21(131):242-8. Prescrire Int. 2012. PMID: 23185849 Review.
-
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25. Eur Urol. 2017. PMID: 27568654
-
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.Eur Urol. 2020 May;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033. Epub 2020 Mar 4. Eur Urol. 2020. PMID: 32146018
-
Obesity and prostate cancer: epidemiology and clinical implications.Eur Urol. 2007 Aug;52(2):331-43. doi: 10.1016/j.eururo.2007.04.069. Epub 2007 May 2. Eur Urol. 2007. PMID: 17507151 Review.
Cited by
-
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis.Prostate Int. 2024 Jun;12(2):96-103. doi: 10.1016/j.prnil.2024.03.003. Epub 2024 Mar 26. Prostate Int. 2024. PMID: 39036754 Free PMC article.
-
Genetic ancestry and radical prostatectomy findings in Hispanic/Latino patients.Front Oncol. 2024 Apr 3;14:1338250. doi: 10.3389/fonc.2024.1338250. eCollection 2024. Front Oncol. 2024. PMID: 38634046 Free PMC article.
-
Phytochemical identification and in silico elucidation of interactions of bioactive compounds from Citrullus lanatus with androgen receptor towards prostate cancer treatment.In Silico Pharmacol. 2024 Apr 7;12(1):27. doi: 10.1007/s40203-024-00193-5. eCollection 2024. In Silico Pharmacol. 2024. PMID: 38596366
-
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.Acta Oncol. 2024 Apr 9;63:154-163. doi: 10.2340/1651-226X.2024.32953. Acta Oncol. 2024. PMID: 38591351 Free PMC article.
-
New role of fat-free mass in cancer risk linked with genetic predisposition.Sci Rep. 2024 Mar 27;14(1):7270. doi: 10.1038/s41598-024-54291-7. Sci Rep. 2024. PMID: 38538606 Free PMC article.
References
-
- Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079– 92. - PubMed
-
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38. - PubMed
-
- Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78. - PubMed
-
- Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235– 41. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical